Phase
Condition
Fibromyalgia
Treatment
Auricular transcutaneous electrical nerve stimulation device
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Meet the American College of Rheumatology (ACR) 1990 classification criteria and theACR 2010 diagnostic criteria for fibromyalgia as determined by clinicians.
Willingness to complete a 4-week, twice-a-day treatments.
At least a 10th grade English-reading level; English can be a second languageprovided that the patients understand all questions used in the assessment measures.
Exclusion
Exclusion Criteria:
Diagnosed with medical conditions that are known to contribute to fibromyalgiasymptomatology, such as thyroid disease, inflammatory arthritis, systemic lupuserythematosus, rheumatoid arthritis, myositis, vasculitis, or Sjogren's syndrome.
History of cardiac, respiratory, or nervous system disease that, in theinvestigator's judgment, precludes participation in the study because of aheightened potential for adverse outcome. For example: asthma or claustrophobia.
Personal history of medical or psychiatric illness as determined by investigator.
Pregnant or lactating.
Less than a 10th grade English-reading level; English can be a second languageprovided that the patients understand all questions used in the assessment measures.
Study Design
Connect with a study center
Massachusetts General Hospital
Charlestown, Massachusetts 02129-2020
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.